Collegium Pharmaceutical Ownership | Who Owns Collegium Pharmaceutical?
Collegium Pharmaceutical Ownership Summary
Collegium Pharmaceutical is owned by 90.35% institutional investors, 2.18% insiders, and 7.48% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 16.15% of COLL shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 6.07% of its assets in Collegium Pharmaceutical shares.
COLL Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Collegium Pharmaceutical | 90.35% | 2.18% | 7.48% |
| Sector | Healthcare Stocks | 232.01% | 10.74% | -142.75% |
| Industry | Specialty & Generic Drug Manufacturers Stocks | 20.82% | 11.62% | 67.56% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock funding, inc. /de | 5.10M | 16.15% | $236.12M |
| Eventide asset management | 2.39M | 7.52% | $83.65M |
| Vanguard group | 2.26M | 7.15% | $104.46M |
| Renaissance | 1.62M | 5.12% | $74.88M |
| Fuller & thaler asset management | 1.50M | 4.75% | $69.45M |
| Rubric capital management lp | 1.50M | 4.74% | $69.28M |
| Principal financial group | 1.31M | 4.16% | $60.82M |
| Massachusetts financial services co /ma/ | 1.31M | 4.16% | $60.78M |
| State street | 1.29M | 4.07% | $45.27M |
| Invesco | 1.28M | 4.03% | $44.89M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Ballast asset management, lp | 110.44K | 2.42% | $5.11M |
| Third avenue management | 203.40K | 1.71% | $9.42M |
| Eventide asset management | 2.39M | 1.38% | $83.65M |
| Emerald advisers | 629.34K | 0.90% | $29.14M |
| Emerald mutual fund advisers trust | 391.67K | 0.88% | $18.13M |
| Rubric capital management lp | 1.50M | 0.83% | $69.28M |
| Summerhaven investment management | 25.75K | 0.68% | $1.19M |
| Jackson creek investment advisors | 38.85K | 0.53% | $1.80M |
| Values first advisors | 17.00K | 0.41% | $787.22K |
| Uniplan investment counsel | 112.03K | 0.38% | $3.92M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Massachusetts financial services co /ma/ | 1.31M | 0.02% | 518.72K |
| Millennium management | 647.83K | 0.01% | 461.91K |
| Assenagon asset management | 511.70K | 0.03% | 316.11K |
| Two sigma investments, lp | 269.32K | 0.01% | 242.31K |
| Walleye capital | 229.19K | 0.03% | 229.19K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Rubric capital management lp | 1.50M | 0.83% | -1.33M |
| Invesco | 1.28M | 0.01% | -301.90K |
| Pacer advisors | - | - | -250.60K |
| Eventide asset management | 2.39M | 1.38% | -250.49K |
| J. goldman & co lp | - | - | -243.45K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Walleye capital | 229.19K | 0.03% | 229.19K | $8.02M |
| Norges bank | 112.50K | 0.00% | 112.50K | $5.21M |
| Wedge capital management l l p/nc | 58.26K | 0.05% | 58.26K | $2.70M |
| Algert global | 57.01K | 0.03% | 57.01K | $2.00M |
| Hrt financial lp | 48.70K | 0.01% | 48.70K | $2.25M |
Sold Out
| Holder | Change |
|---|---|
| Clearstead advisors | -1.00 |
| Stephens consulting | -1.00 |
| Larson financial group | -2.00 |
| Lindbrook capital | -2.00 |
| Mendota financial group | -4.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 189 | -22.54% | 28,523,231 | -22.90% | 90 | 0.67% | 83 | -36.15% | 77 | -10.47% |
| Sep 30, 2025 | 232 | 7.91% | 36,812,079 | 7.39% | 115 | 1.00% | 123 | 14.95% | 84 | 6.33% |
| Jun 30, 2025 | 219 | -10.61% | 35,601,778 | -3.13% | 111 | 0.84% | 106 | -2.75% | 83 | -15.31% |
| Mar 31, 2025 | 2 | -99.17% | 369,275 | -99.01% | 1 | 0.01% | 1 | -99.07% | 1 | -98.91% |
| Dec 31, 2024 | 239 | -5.16% | 37,025,520 | -3.74% | 114 | 0.81% | 105 | -25.53% | 93 | 22.37% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| iShares Core S&P Small-Cap ETF | 1.92M | 6.07% | -272.99K |
| FullerThaler Behavioral Sm-Cp Eq R6 | 1.43M | 4.53% | 63.90K |
| FullerThaler Behavioral Small-Cap Equity | 1.43M | 4.53% | 63.90K |
| Eventide Gilead N | 1.34M | 4.25% | - |
| Eventide Healthcare & Life Sciences I | 1.03M | 3.27% | -250.34K |
| Vanguard US Total Market Shares ETF | 993.93K | 3.09% | - |
| Vanguard Total Stock Mkt Idx Inv | 935.67K | 2.96% | - |
| Janus Henderson Hrzn Glb SC E2 USD | 925.82K | 2.93% | 80.39K |
| iShares Russell 2000 ETF | 757.67K | 2.40% | 7.03K |
| Principal U.S. Small Cap Equity | 548.50K | 1.74% | -3.40K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Mar 03, 2026 | Dreyer Scott | EVP & Chief Commercial Officer | Sell | $145.88K |
| Mar 03, 2026 | Dreyer Scott | EVP & Chief Commercial Officer | Sell | $1.87M |
| Dec 08, 2025 | Dreyer Scott | EVP & Chief Commercial Officer | Sell | $315.08K |
| Dec 08, 2025 | Dreyer Scott | EVP & Chief Commercial Officer | Sell | $532.77K |
| Dec 05, 2025 | Balice-Gordon Rita J. | - | Sell | $171.67K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q1 | - | 2 |
| 2025 Q4 | - | 6 |
| 2025 Q3 | - | 6 |
| 2025 Q2 | - | 1 |
| 2025 Q1 | - | 18 |
COLL Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools